Despite falling short on the bottom line, the H1 23 results were in line with the street’s expectations in terms of the top-line and operating profit. The challenges posed by high comps and the effects of the COVID period significantly impacted tobacco volumes but this decline was effectively mitigated by pricing strategies. In our assessment, the market’s lukewarm response to the results can be attributed to a perceived lack of catalysts for Imperial.